CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $546,373
- in 2 filings
Net −$546,373. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | Donley Matthew Maxwell Chief Operating Officer | Shares withheld for taxes | −32,901 | $14.40 | $474K | 662,900 |
| 2026-02-20 | Greenleaf Peter Chief Executive Officer | Shares withheld for taxes | −100,171 | $14.40 | $1.4M | 1,744,866 |
| 2026-02-02 | Keenan Greg SVP, Chief Medical Officer | Shares withheld for taxes | −11,552 | $14.53 | $168K | 121,932 |
| 2026-01-02 | Robertson Stephen P. EVP, General Counsel | Grant or award | +48,558 | 557,434 | ||
| 2026-01-02 | Robertson Stephen P. EVP, General Counsel | Shares withheld for taxes | −40,385 | $15.95 | $644K | 517,934 |
| 2026-01-02 | Donley Matthew Maxwell Chief Operating Officer | Grant or award | +54,166 | 734,631 | ||
| 2026-01-02 | Donley Matthew Maxwell Chief Operating Officer | Shares withheld for taxes | −42,787 | $15.95 | $682K | 695,801 |
| 2026-01-02 | Miller Joseph M Chief Financial Officer | Grant or award | +49,038 | 626,399 | ||
| 2026-01-02 | Miller Joseph M Chief Financial Officer | Shares withheld for taxes | −40,161 | $15.95 | $641K | 589,127 |
| 2026-01-02 | Greenleaf Peter Chief Executive Officer | Grant or award | +165,384 | 1,954,329 | ||
| 2026-01-02 | Greenleaf Peter Chief Executive Officer | Shares withheld for taxes | −113,169 | $15.95 | $1.8M | 1,845,037 |
| 2025-11-21 | Bailey Jeffrey Allen Director | Shares withheld for taxes | −2,716 | $15.68 | $43K | 22,775 |
| 2025-11-21 | Johnson Craig A Director | Shares withheld for taxes | −6,039 | $15.68 | $95K | 14,592 |
| 2025-08-05 | TANG KEVIN Director | Purchase | +200,000 | $11.68 | $2.3M | 11,329,500 |
| 2025-08-04 | TANG KEVIN Director | Purchase | +100,000 | $11.34 | $1.1M | 11,129,500 |
| 2025-08-01 | Keenan Greg Chief Medical Officer | Sale | −20,000 | $10.50 | $210K | 133,484 |
| 2025-08-01 | TANG KEVIN Director | Purchase | +1,000,000 | $10.12 | $10.1M | 11,029,500 |
| 2025-05-16 | Nova Tina Susan Director | Grant or award · Director Stock Option (right to buy) | +63,724 | 63,724 | ||
| 2025-05-16 | Johnson Craig A Director | Grant or award · Director Stock Option (right to buy) | +37,485 | 37,485 | ||
| 2025-05-16 | Goetz Kathleen Director | Grant or award · Director Stock Option (right to buy) | +63,724 | 63,724 |
Page 3 of 10 · 197 trades